Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Temporarily pausedNCT04036721
What this trial is testing

Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis

Who this might be right for
Lung Neoplasm MalignantInterstitial Lung Disease
National Institute for Tuberculosis and Lung Diseases, Poland 85
Not applicableNot Yet RecruitingNCT06682247
What this trial is testing

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Feng Wang 200
Testing effectiveness (Phase 2)Study completedNCT04834674
What this trial is testing

DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaTransarterial ChemoembolizationApatinib+1 more
Sichuan Cancer Hospital and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT03322540
What this trial is testing

Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)

Who this might be right for
Lung Cancer
Incyte Corporation 154
Large-scale testing (Phase 3)Not Yet RecruitingNCT06900218
What this trial is testing

PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 664
Testing effectiveness (Phase 2)UnknownNCT05741021
What this trial is testing

A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung CancerNSCLCPD-1
Shandong New Time Pharmaceutical Co., LTD 84
Large-scale testing (Phase 3)UnknownNCT04167293
What this trial is testing

Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01)

Who this might be right for
Hepatocellular Carcinoma
Mian XI 116
Testing effectiveness (Phase 2)Study completedNCT03014648
What this trial is testing

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced Non-small Cell Lung Cancer
Liza Villaruz, MD 28
Early research (Phase 1)WithdrawnNCT05717140
What this trial is testing

Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the LungMetastatic Melanoma+2 more
Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT05837806
What this trial is testing

Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)

Who this might be right for
Neoadjuvant Immunotherapy
Tianjin Medical University Second Hospital 21
Large-scale testing (Phase 3)UnknownNCT03605706
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.

Who this might be right for
Advanced Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 396
Large-scale testing (Phase 3)Ended earlyNCT02967692
What this trial is testing

The Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 568
Testing effectiveness (Phase 2)Looking for participantsNCT06840834
What this trial is testing

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 38
Testing effectiveness (Phase 2)Looking for participantsNCT05978193
What this trial is testing

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal CancerMetastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04701307
What this trial is testing

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

Who this might be right for
Lung Small Cell CarcinomaNeuroendocrine CarcinomaStage III Lung Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT03958097
What this trial is testing

Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The First Hospital of Jilin University 20
Not applicableLooking for participantsNCT04615988
What this trial is testing

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

Who this might be right for
ThyroidPD-1Cancer
Icahn School of Medicine at Mount Sinai 17
Testing effectiveness (Phase 2)Study completedNCT04570410
What this trial is testing

Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma

Who this might be right for
Bladder Urothelial Carcinoma
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)Ended earlyNCT03463161
What this trial is testing

Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Cancer
University of Chicago 2
Testing effectiveness (Phase 2)Looking for participantsNCT06438822
What this trial is testing

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
West China Hospital 51
Next Page